Bill Snyder Archive — Page 78 of 119
-
November 7, 2016
Early study finds antibody that ‘neutralizes’ Zika virus
Researchers at Vanderbilt University Medical Center and Washington University School of Medicine in St. Louis have isolated a human monoclonal antibody that in a mouse model “markedly reduced” infection by the Zika virus. -
November 3, 2016
Brown named interim director of Institute of Chemical Biology
H. Alex Brown, Ph.D., the Bixler-Johnson-Mayes Professor in the Department of Pharmacology, has been named interim director of the Vanderbilt Institute of Chemical Biology (VICB). -
October 27, 2016
Vanderbilt’s Dugan, Patel, Wallace set for Discovery Lecture
Three Vanderbilt University neuroscientists on the forefront of research in autism, addiction and Alzheimer’s disease will discuss their cutting-edge investigations during the next Flexner Discovery Lecture on Thursday, Nov. 3. -
October 27, 2016
Iadecola set for Oates Lectureship in Clinical Pharmacology
Costantino Iadecola, M.D., an expert in the molecular pathology of ischemic brain injury and neurodegeneration at Weill Cornell Medical College in New York, will present the 10th annual Meredith S. and John A. Oates Lectureship in Clinical Pharmacology on Nov. 3. -
October 21, 2016
DNA damage response protein
Vanderbilt researchers have determined that a previously uncharacterized protein responds to DNA replication stress and has an essential role in maintaining the integrity of the genome. -
October 20, 2016
Preparing for a return of pox
To prepare for the potential of a smallpox return, Vanderbilt researchers are isolating and studying naturally occurring antibodies from the blood of previously infected or immunized people.